{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=PF-04950615", "query": { "intervention": "PF-04950615" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 17, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=PF-04950615&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-05T09:53:14.522Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01975389", "title": "The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cardiovascular Disease" ], "interventions": [ { "name": "bococizumab (PF-04950615)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 10564, "start_date": "2013-10-29", "completion_date": "2017-04-03", "has_results": true, "last_update_posted_date": "2019-05-01", "last_synced_at": "2026-09-05T09:53:14.522Z", "location_count": 518, "location_summary": "Athens, Alabama • Birmingham, Alabama • Fort Payne, Alabama + 328 more", "locations": [ { "city": "Athens", "state": "Alabama" }, { "city": "Athens", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT01975389" }, { "nct_id": "NCT01592240", "title": "Monthly And Twice Monthly Subcutaneous Dosing Of PF-04950615 (RN316) In Hypercholesterolemic Subjects On A Statin", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hypercholesterolemia" ], "interventions": [ { "name": "PBO", "type": "DRUG" }, { "name": "200mg PF-04950615 (RN316)", "type": "DRUG" }, { "name": "300mg PF-04950615 (RN316)", "type": "DRUG" }, { "name": "PF-04950615", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 354, "start_date": "2012-07", "completion_date": "2013-05", "has_results": true, "last_update_posted_date": "2017-12-05", "last_synced_at": "2026-09-05T09:53:14.522Z", "location_count": 74, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Tucson, Arizona + 59 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01592240" }, { "nct_id": "NCT01968954", "title": "Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hyperlipidemia" ], "interventions": [ { "name": "Bococizumab (PF-04950615;RN316)", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 711, "start_date": "2013-10", "completion_date": "2016-04", "has_results": true, "last_update_posted_date": "2017-05-17", "last_synced_at": "2026-09-05T09:53:14.522Z", "location_count": 58, "location_summary": "Birmingham, Alabama • Tucson, Arizona • Encinitas, California + 45 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Encinitas", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01968954" }, { "nct_id": "NCT01163851", "title": "Pharmacokinetic And Pharmacodynamic Study Of A Single-Dose Of PF-04950615 (RN316) In Combination With Atorvastatin", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hypercholesterolemia", "Dyslipidemia" ], "interventions": [ { "name": "4 mg/kg", "type": "BIOLOGICAL" }, { "name": "0.5 mg/kg", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 25, "start_date": "2010-07", "completion_date": "2011-04", "has_results": true, "last_update_posted_date": "2018-03-01", "last_synced_at": "2026-09-05T09:53:14.522Z", "location_count": 5, "location_summary": "Peoria, Arizona • Phoenix, Arizona • Overland Park, Kansas", "locations": [ { "city": "Peoria", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Overland Park", "state": "Kansas" }, { "city": "Overland Park", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01163851" }, { "nct_id": "NCT01968980", "title": "A 52 Week Study To Assess The Use Of Bococizumab (PF-04950615; RN316) In Subjects With Heterozygous Familial Hypercholesterolemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Heterozygous Familial Hypercholesterolemia" ], "interventions": [ { "name": "Bococizumab (PF-04950615;RN316)", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 370, "start_date": "2013-10-23", "completion_date": "2016-04-15", "has_results": true, "last_update_posted_date": "2017-06-26", "last_synced_at": "2026-09-05T09:53:14.522Z", "location_count": 22, "location_summary": "Los Angeles, California • Hartford, Connecticut • Hialeah, Florida + 13 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Hartford", "state": "Connecticut" }, { "city": "Hialeah", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01968980" }, { "nct_id": "NCT02043301", "title": "Pharmacokinetics And Relative Bioavailability Of Bococizumab (PF-04950615; RN316) When Administered To The Abdomen, Thigh Or Upper Arm", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hypercholesterolemia" ], "interventions": [ { "name": "Bococizumab (PF-04950615; RN316)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 75, "start_date": "2014-04", "completion_date": "2014-11", "has_results": true, "last_update_posted_date": "2019-05-31", "last_synced_at": "2026-09-05T09:53:14.522Z", "location_count": 6, "location_summary": "Anaheim, California • South Miami, Florida • Overland Park, Kansas + 1 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "South Miami", "state": "Florida" }, { "city": "South Miami", "state": "Florida" }, { "city": "Overland Park", "state": "Kansas" }, { "city": "Overland Park", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02043301" }, { "nct_id": "NCT01350141", "title": "A Multiple Dose Study Of PF-04950615 (RN316) In Subjects On Maximum Doses Of Statins", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hypercholesterolemia", "Dyslipidemia" ], "interventions": [ { "name": "Placebo", "type": "OTHER" }, { "name": "PF-04950615 (RN316)", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 46, "start_date": "2011-06", "completion_date": "2012-06", "has_results": true, "last_update_posted_date": "2017-11-08", "last_synced_at": "2026-09-05T09:53:14.522Z", "location_count": 29, "location_summary": "Birmingham, Alabama • Garden Grove, California • Long Beach, California + 18 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Garden Grove", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Wildomar", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01350141" }, { "nct_id": "NCT01975376", "title": "The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cardiovascular Disease" ], "interventions": [ { "name": "bococizumab (PF-04950615)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 16784, "start_date": "2013-10-29", "completion_date": "2017-03-22", "has_results": true, "last_update_posted_date": "2018-07-11", "last_synced_at": "2026-09-05T09:53:14.522Z", "location_count": 545, "location_summary": "Athens, Alabama • Birmingham, Alabama • Fort Payne, Alabama + 339 more", "locations": [ { "city": "Athens", "state": "Alabama" }, { "city": "Athens", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT01975376" }, { "nct_id": "NCT01342211", "title": "A Multiple Dose Study of PF-04950615 (RN316) in Subjects on High Doses of Statins", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hypercholesterolemia", "Dyslipidemia" ], "interventions": [ { "name": "Placebo", "type": "BIOLOGICAL" }, { "name": "Statin", "type": "DRUG" }, { "name": "PF-04950615 (RN316)", "type": "BIOLOGICAL" }, { "name": "Satin", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 93, "start_date": "2011-07", "completion_date": "2012-06", "has_results": true, "last_update_posted_date": "2017-10-11", "last_synced_at": "2026-09-05T09:53:14.522Z", "location_count": 38, "location_summary": "Tustin, California • Walnut Creek, California • Clearwater, Florida + 25 more", "locations": [ { "city": "Tustin", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Clearwater", "state": "Florida" }, { "city": "DeLand", "state": "Florida" }, { "city": "Doral", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01342211" }, { "nct_id": "NCT02135029", "title": "Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects Who Are Intolerant to Statins", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hyperlipidemia" ], "interventions": [ { "name": "Bococizumab (PF-04950615;RN316)", "type": "DRUG" }, { "name": "Atorvastatin", "type": "DRUG" }, { "name": "Placebo for Bococizumab (PF-04950615;RN316)", "type": "OTHER" }, { "name": "Placebo for atorvastatin", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 184, "start_date": "2014-06", "completion_date": "2015-11", "has_results": true, "last_update_posted_date": "2017-12-14", "last_synced_at": "2026-09-05T09:53:14.522Z", "location_count": 31, "location_summary": "Denver, Colorado • Bridgeport, Connecticut • Lakeland, Florida + 24 more", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "Bridgeport", "state": "Connecticut" }, { "city": "Lakeland", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Ponte Vedra", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02135029" } ] }